Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: A potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphoma

International Journal of Cancer

Volumn 93, Issue 5, 2001, Pages 706-713

  Gahn, Benedikt ^b   Siller Lopez, Fernando ^b   Pirooz, Angela D ^b   Yvon, Eric ^b   Gottschalk, Stephen ^b   Longnecker, Richard ^b   Brenner, Malcolm K ^a   Heslop, Helen E ^a   Aguilar Cordova, Estuardo ^a   Rooney, Cliona M ^a  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cytotoxic T lymphocytes; Dendritic cells; Epstein Barr virus; Hodgkin's lymphoma; LMP2A; Recombinant adenovirus

Indexed keywords

COMPLEMENTARY DNA; VIRUS DNA;

ADENOVIRUS; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; FUSION GENE; GENE TRANSFER; GENETIC TRANSDUCTION; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; PRIORITY JOURNAL; TARGET CELL; VACCINIA VIRUS; VIRUS GENE;

ADENOVIRIDAE; CELL AGING; CELLS, CULTURED; DENDRITIC CELLS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; LEUKOCYTES, MONONUCLEAR; LUMINESCENT PROTEINS; LYMPHOCYTE ACTIVATION; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; VIRAL MATRIX PROTEINS;

EID: 0035452356     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1396     Document Type: Article

References (39)

1. Treatment of advanced Hodgkin's lymphoma: Standard and experimental approaches
2. Problems in Hodgkin's disease management
3. Secondary leukaemia and myelodysplasia after autografting for lymphoma: Results from the EBMT
4. High incidence of Epstein-Barr virus genomes in Hodgkin's disease
5. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease
6. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation
7. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes
8. EBV-specific cytotoxic T lymphocytes for the treatment of patients with EBV positive relapsed Hodgkin's disease
9. + malignancies
10. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Stemberg cells
11. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection
12. BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 protooncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes
13. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1
14. Isolation of Epstein-Barr virus (EBV)-specific cytotoxic T Lymphocytes that lyse Reed-Stemberg cells: Implications for immune-medicated therapy of EBV Hodgkin's disease
15. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): Evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes
16. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations
17. Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue
18. Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: A critical role for antigen expression
19. Analysis of major histocompatibility complex class I, TAP expression, and LMP2 epitope sequence in Epstein-Barr virus-positive Hodgkin's disease
20. Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene
21. Accessing Epstein-Barr virus-specific T-cell memory with peptide-loaded dendritic cells
22. Dendritic cells generated from human blood in granulocyte macrophage-colony stimulating factor and interleukin-7
23. Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus
24. + T cells in patients with melanoma
25. Human PBMC-derived dendritic cells transduced with an adenovirus vector induce cytotoxic T-lymphocyte responses against a vector-encoded antigen in vitro
26. Enrichment of an antigen-specific T cell response by retrovirally transduced human dendritic cells
27. Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: A new modality for vaccination
28. Two related Epstein-Barr virus membrane proteins are encoded by separate genes
29. Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis
30. A simplified system for generating recombinant adenoviruses
31. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability
32. Sensitivity and reproducibility in adenoviral infectious titer determination
33. Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus
34. Immune response to green fluorescent protein: Implications for gene therapy
35. Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gpl00 for cancer therapy
36. A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro
37. Construction and characterization of a recombinant adenovirus directing expression of the MAGE-1 tumor-specific antigen
38. Dendritic cells loaded with MART-1 peptide or infected with adenoviral construct are functionally equivalent in the induction of tumor-specific cytotoxic T lymphocyte responses in patients with melanoma
39. Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro